| RS1380850249 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS138085358 |
SLC1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 6, Episodic ataxia type 6 |
| RS138085418 |
EXOSC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS1380858784 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome |
| RS138086769 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital factor V deficiency |
| RS138087003 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1380872774 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1380876424 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS138087806 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
USH2A-related disorder, USH2A-related disorder |
| RS1380878336 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Alport syndrome |
| RS138088528 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1380889353 |
PROS1
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS138088984 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS138089183 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS138089753 |
FKBP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, FKBP10-related disorder |
| RS1380904813 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS1380918472 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1380919500 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS138092189 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
NPHS1-related disorder, NPHS1-related disorder |
| RS1380925561 |
ARFGEF2
|
Health Risk |
Pathogenic |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS138092785 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease 2 |
| RS1380932561 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1380940215 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS138094037 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1380941851 |
TECTA
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12 |
| RS138094550 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, SLC25A13-related disorder |
| RS138094960 |
BAAT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1380954046 |
GOSR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1380965800 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS1380968057 |
ZNF142
|
Health Risk |
Pathogenic |
— |
| RS138097673 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS138097741 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1380982250 |
ANKLE2
|
Health Risk |
Pathogenic |
Microcephaly 16, primary |
| RS138098342 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS138098371 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Inborn genetic diseases |
| RS1380984220 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS138098808 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS138099253 |
STXBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 5, Autoinflammatory syndrome |
| RS1380999715 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS138100360 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Pityriasis rubra pilaris |
| RS1381005435 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1381007585 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, KIT-related disorder |
| RS138100963 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS138101005 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS1381011685 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 6, Wolfram syndrome 1 |
| RS138101305 |
CASQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Myopathy due to calsequestrin and SERCA1 protein overload |
| RS1381017299 |
C8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Type I complement component 8 deficiency, Type I complement component 8 deficiency |
| RS138102615 |
SUGCT
|
Health Risk |
Conflicting classifications of pathogenicity |
SUGCT-related disorder, SUGCT-related disorder |
| RS138103656 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1381038824 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1381041583 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1381042061 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS138105298 |
OAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138105395 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Inborn genetic diseases |
| RS1381057964 |
NLRP5
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 19, Oocyte/zygote/embryo maturation arrest 19 |
| RS138105834 |
TP53BP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1381062033 |
TMC1
|
Health Risk |
Pathogenic |
— |
| RS138106524 |
AIMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138106612 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
RP1-related disorder, RP1-related disorder |
| RS1381068943 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS1381069212 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS138107415 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS138108105 |
PRMT7
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS138108276 |
TTI2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1381087007 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS1381090737 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS138109666 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS138110172 |
CLCNKA
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 4B, Bartter disease type 4B |
| RS138110910 |
MYH7
|
Health Risk |
Pathogenic |
Left ventricular noncompaction 5, Left ventricular noncompaction 5 |
| RS138111360 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1381117009 |
COL4A5
|
Health Risk |
Pathogenic |
Alport syndrome, Alport syndrome |
| RS138111804 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay, hypotonia |
| RS138111911 |
ROBO4
|
Health Risk |
Likely pathogenic |
Ascending tubular aorta aneurysm, Bicuspid aortic valve |
| RS138112218 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1381141633 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS138114191 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS138114586 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Autoimmune thyroid disease |
| RS138114609 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS138114979 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1381150705 |
SLCO2A1
|
Health Risk |
Pathogenic |
— |
| RS138115393 |
RASA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1381160481 |
DENND5A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS138116135 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sifrim-Hitz-Weiss syndrome, Inborn genetic diseases |
| RS1381162017 |
SEC63
|
Health Risk |
Pathogenic |
— |
| RS1381167403 |
PLCG2
|
Health Risk |
Pathogenic |
Familial cold autoinflammatory syndrome 3, Familial cold autoinflammatory syndrome 3 |
| RS138118085 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1381186128 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1381188740 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS138119149 |
AARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 8, Inborn genetic diseases |
| RS138120505 |
KCNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 2, Inborn genetic diseases |
| RS138121153 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS138121304 |
LARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome, Perrault syndrome 4 |
| RS138121813 |
CNTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS138122556 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 52 |
| RS138123187 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Combined oxidative phosphorylation deficiency |
| RS1381237268 |
SPG11
|
Health Risk |
Pathogenic |
— |
| RS1381239923 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS138124482 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, NPHP3-related disorder |
| RS138125166 |
THSD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, THSD4-related disorder |
| RS138125299 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Inborn genetic diseases |